Duration: 44 minutes
Alterations in glycosylation have long been associated with the development and progression of many types of chronic and acute diseases. In this webinar, I will discuss how we have been generating new applications utilizing MALDI Mass Spectrometry Imaging to create innovative solutions to roadblocks in biomarker discovery and clinical assay development.
Danielle A. Scott Ph.D.
Chief Officer of Product Development at GlycoPath and Visiting Scientist at the Medical University of South Carolina
For Research Use Only. Not for use in clinical diagnostic procedures.